Browse All

Current Filters

CLEAR FILTER x

TITLE

A 2-Stage Model of Heterogenous Treatment Effects for Brain Atrophy in MS Utilizing the MS PATHS Research Network

Author:Hersh, Carrie   Sun, Zhaonan   Grossman, Cynthia   Shen, Changyu   Pellegrini, Fabio   Campbell, Nolan   

Session Name:S27: MS Neuroimaging  

Topic:MS and Inflammatory Disease  

Program Number:S27.001  

Author Institution:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  Biogen Digital Health, Biogen Inc., Cambridge, MA  

Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years

Author:Alvarez, Enrique   Hersh, Carrie   Robertson, Derrick   Das Gupta, Ayan   Hu, Xixi   Zielman, Ronald   Boer, Ibolya   Cheadle, Andy   Cohen, Jeffrey   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.002  

Author Institution:Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado , Aurora, CO  Lou Ruvo Center for Brain Health, Cleveland Clinic Mellen Program for MS, Las Vegas, NV  Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL  Novartis Healthcare, Hyderabad, India  Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Pharma B.V., Amsterdam, Netherlands  Novartis Pharma AG, Basel, Switzerland  Department of Neurology, Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH